Prep kit for Technetium Tc99 Sestamibi for Injection Articles

B-MS's earnings hit $714M in 1st-qtr

8 May 2006

Amersham's Myoview approved for new use

10 March 2003

Point Bio starts Ph III trial of contrast agent

19 August 2002

Syncor sales up 31% in 2nd quarter

5 August 2002

Bristol-Myers Squibb buys DuPont Pharma for $7.8 billion

11 June 2001

US 1st-quarter results continue to flow in

3 May 2000

Latest crop of full-year results show strong sales growth for US pharma

3 February 2000

US budget bill includes reprieves for Medicare payments on Rx drugs

8 December 1999

DuPont Buys Out Merck's Stake In JV For $2.6 Billion

21 May 1998

Amersham's Myoview Gets FDA Go-Ahead

19 February 1996

High Accuracy For Sestamibi Diagnostic

19 December 1994

Amersham Plugs Japan Gap With Key Alliance

17 October 1994

WELLCOME'S RHEOTHRx CUTS INFARCT SIZE

11 April 1994

Showing 1-13 of 13 articles

Go to beginningPrevious
  • 1
NextGo to end